2
项与 JNJ-69095897 相关的临床试验A 3-Part, Randomized, Placebo-controlled, Double-blind, Single Ascending Dose Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ69095897 in Healthy Participants - A*Study to*Investigate*Safety and*Pharmacokinetics of JNJ-69095897
A 3-Part, Randomized, Placebo-controlled, Double-blind, Single Ascending Dose Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-69095897 in Healthy Participants
The purpose of this study is to investigate the safety and tolerability of JNJ-69095897 versus placebo and to characterize the pharmacokinetic (PK) of JNJ-69095897 in blood, plasma, cerebrospinal fluid (CSF) and urine after single or divided oral dose administration in healthy participants.
100 项与 JNJ-69095897 相关的临床结果
100 项与 JNJ-69095897 相关的转化医学
100 项与 JNJ-69095897 相关的专利(医药)
100 项与 JNJ-69095897 相关的药物交易